## Abstract Ten patients with focal dystonia of the hand, all of whom had benefited in an openβlabel study of botulinum toxin, were treated with botulinum toxinβA in a doubleβblind study. Response was assessed by three measures: (a) subjective rating, provided by patients' reports of the effect of
Botulinum toxin a injections for the treatment of hand tremors
β Scribed by R. M. Trosch; Dr. S. L. Pullman
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 738 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
We conducted an openβlabel study to determine the utility of treating severe hand tremors with intramuscular injections of botulinum toxin (BTX) in forearm and arm muscles in 26 patiets, 12 with Parkinson's disease (PD) and 14 with essential tremor (ET). The effect after 6 weeks for each patient was evaluated using two clinical rating scales, subjective evaluations of functional improvement and global disability, measures of weakness, and computerβassisted quantitative assessments of tremor. Although none of the clinical scores averaged>3/4 point change, statistical significance was found on comparison of preβ and postinjection scores in the Webster Tremor and Global Disability Scales in the ET patients. Similarly, although average tremor amplitudes decreased by no more than 25% by quantitative analysis, amplitude decrease significantly correlated with patient subjective assessment in ET. In only two of 12 PD (17%) and three of 14 ET patients (21%) were major quantitative changes in tremor amplitude (>50% reduction) found after BTX injections. Nevertheless, 10 patients (38%; five PD and five ET) reported moderate to marked subjective improvement in functional benefit after BTX. These finding suggest that although there were no major changes in clinical ratings or objective measurements, BTX injections may subjectively improve tremor in some patients, particularly those with ET.
π SIMILAR VOLUMES
## Abstract Jaw tremor in Parkinson's disease (PD) may not respond well to conventional treatment. It causes embarrassment and social handicap. We piloted the use of botulinum toxin (BTX) injections in three patients with PD jaw tremor. BTX A (Dysport; mean, 53 U; range, 30β100 U) was given into ea
Chemodenervation of cervical muscles with botulinum A toxin, although useful in treating spasmodic torticollis, has been associated with dysphagia. Retrospective analysis of dose and injection site (sternomastoid vs. posterior cervical muscle groups) in 26 patients (49 injections) suggested that dys
## Abstract ## Aims To review the available literature on the application of botulinum toxin in the urinary tract, with particular reference to its use in treating detrusor overactivity (DO). ## Methods Botulinum toxin, overactive bladder (OAB), detrusor instability, DO, detrusor sphincter dyssy